The estimated Net Worth of Edward M Straw is at least $10 Tysiąc dollars as of 10 September 2015. Edward Straw owns over 12,500 units of Helius Medical Technologies Inc stock worth over $10,000 and over the last 21 years Edward sold HSDT stock worth over $0.
Edward has made over 2 trades of the Helius Medical Technologies Inc stock since 2004, according to the Form 4 filled with the SEC. Most recently Edward bought 12,500 units of HSDT stock worth $10,000 on 10 September 2015.
The largest trade Edward's ever made was buying 12,500 units of Helius Medical Technologies Inc stock on 10 September 2015 worth over $10,000. On average, Edward trades about 1,654 units every 317 days since 2003. As of 10 September 2015 Edward still owns at least 12,500 units of Helius Medical Technologies Inc stock.
You can see the complete history of Edward Straw stock trades at the bottom of the page.
Edward's mailing address filed with the SEC is C/O HELIUS MEDICAL TECHNOLOGIES, INC., 642 NEWTOWN YARDLEY ROAD, SUITE 100, NEWTOWN, PA, 18940.
Over the last 9 years, insiders at Helius Medical Technologies Inc have traded over $0 worth of Helius Medical Technologies Inc stock and bought 1,827,117 units worth $3,547,767 . The most active insiders traders include Dane Andreeff, Blane Walter oraz Philippe Deschamps. On average, Helius Medical Technologies Inc executives and independent directors trade stock every 121 days with the average trade being worth of $58,628. The most recent stock trade was executed by Dane Andreeff on 14 December 2023, trading 5,000 units of HSDT stock currently worth $40,500.
helius medical technologies, inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-invasive technologies for the treatment of symptoms caused by neurological disease or trauma. the company's product is portable neuromodulation stimulator (pons), a medical device in canada for the treatment of chronic balance deficit due to mild-to-moderate traumatic brain injury. its pons device treats neurostimulation of cranial nerves via the tongue to restore lost function. the company is headquartered in newtown, pennsylvania.
Helius Medical Technologies Inc executives and other stock owners filed with the SEC include: